PREDICTIVE ONCOLOGY INC (POAI) Stock Price, Quote, News and Overview
NASDAQ:POAI - Nasdaq - US74039M3097 - Common Stock - Currency: USD
POAI Quote, Performance and Key Statistics
1.1
+0.03 (+2.8%)
The current stock price of POAI is 1.1 USD. In the past month the price increased by 15.97%. In the past year, price decreased by -34.52%.
POAI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.9 | 231.27B | ||
| ISRG | INTUITIVE SURGICAL INC | 73.34 | 200.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.84 | 155.10B | ||
| SYK | STRYKER CORP | 31.3 | 149.70B | ||
| MDT | MEDTRONIC PLC | 16.13 | 110.44B | ||
| BDX | BECTON DICKINSON AND CO | 12.23 | 49.47B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.57 | 45.20B | ||
| IDXX | IDEXX LABORATORIES INC | 44.91 | 41.49B | ||
| RMD | RESMED INC | 27.38 | 36.45B | ||
| DXCM | DEXCOM INC | 51.92 | 33.59B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.85 | 33.38B | ||
| STE | STERIS PLC | 26.43 | 24.26B |
Related stock screener links
About POAI
Company Profile
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 23 full-time employees. The company went IPO on 2009-12-18. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The firm offers a suite of solutions for oncology drug development from early discovery to clinical trials.
Company Info
PREDICTIVE ONCOLOGY INC
91 43Rd Street, Suite 110
Pittsburgh PENNSYLVANIA 55121 US
CEO: Carl Schwartz
Employees: 24
Phone: 14124321500
PREDICTIVE ONCOLOGY INC / POAI FAQ
What is the stock price of PREDICTIVE ONCOLOGY INC today?
The current stock price of POAI is 1.1 USD. The price increased by 2.8% in the last trading session.
What is the ticker symbol for PREDICTIVE ONCOLOGY INC stock?
The exchange symbol of PREDICTIVE ONCOLOGY INC is POAI and it is listed on the Nasdaq exchange.
On which exchange is POAI stock listed?
POAI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PREDICTIVE ONCOLOGY INC stock?
6 analysts have analysed POAI and the average price target is 3.06 USD. This implies a price increase of 178.18% is expected in the next year compared to the current price of 1.1. Check the PREDICTIVE ONCOLOGY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PREDICTIVE ONCOLOGY INC worth?
PREDICTIVE ONCOLOGY INC (POAI) has a market capitalization of 9.82M USD. This makes POAI a Nano Cap stock.
How many employees does PREDICTIVE ONCOLOGY INC have?
PREDICTIVE ONCOLOGY INC (POAI) currently has 24 employees.
What are the support and resistance levels for PREDICTIVE ONCOLOGY INC (POAI) stock?
PREDICTIVE ONCOLOGY INC (POAI) has a support level at 1.1 and a resistance level at 1.12. Check the full technical report for a detailed analysis of POAI support and resistance levels.
Is PREDICTIVE ONCOLOGY INC (POAI) expected to grow?
The Revenue of PREDICTIVE ONCOLOGY INC (POAI) is expected to decline by -53.24% in the next year. Check the estimates tab for more information on the POAI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PREDICTIVE ONCOLOGY INC (POAI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of POAI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of POAI, evaluating the profitability, health, valuation and growth aspects
- PREDICTIVE ONCOLOGY INC (POAI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PREDICTIVE ONCOLOGY INC (POAI) Sales and EPS estimates to see what analysts future expectations are.
- PREDICTIVE ONCOLOGY INC (POAI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PREDICTIVE ONCOLOGY INC (POAI) Insider and Institutional Ownership to learn about the owners and their transactions.
- PREDICTIVE ONCOLOGY INC (POAI) Stock Chart to make your own analysis
- PREDICTIVE ONCOLOGY INC (POAI) Latest news and press-releases to stay up to date.
Does PREDICTIVE ONCOLOGY INC (POAI) stock pay dividends?
POAI does not pay a dividend.
When does PREDICTIVE ONCOLOGY INC (POAI) report earnings?
PREDICTIVE ONCOLOGY INC (POAI) will report earnings on 2025-08-12.
What is the Price/Earnings (PE) ratio of PREDICTIVE ONCOLOGY INC (POAI)?
PREDICTIVE ONCOLOGY INC (POAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.37).
What is the Short Interest ratio of PREDICTIVE ONCOLOGY INC (POAI) stock?
The outstanding short interest for PREDICTIVE ONCOLOGY INC (POAI) is 2.3% of its float. Check the ownership tab for more information on the POAI short interest.
POAI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to POAI. When comparing the yearly performance of all stocks, POAI is a bad performer in the overall market: 87.74% of all stocks are doing better.
POAI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to POAI. Both the profitability and financial health of POAI have multiple concerns.
POAI Financial Highlights
Over the last trailing twelve months POAI reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS increased by 27.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -254.69% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
POAI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to POAI. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 14.54% and a revenue growth -53.24% for POAI